73 related articles for article (PubMed ID: 19198274)
21. [Hemostasis system disturbances and their correction in patients with pyonecrotic forms of diabetic foot].
Svetukhin AM; Amiraslanov IuA; Zemlianoĭ AB; Titiova MI; Istratov VG; Rudneva VG; Egorova VV; Korotkina RN; Terekhova RP; Doronina LP
Khirurgiia (Mosk); 2006; (10):30-4. PubMed ID: 17159864
[TBL] [Abstract][Full Text] [Related]
22. Diagnosing diabetic foot osteomyelitis: is the combination of probe-to-bone test and plain radiography sufficient for high-risk inpatients?
Aragón-Sánchez J; Lipsky BA; Lázaro-Martínez JL
Diabet Med; 2011 Feb; 28(2):191-4. PubMed ID: 21219428
[TBL] [Abstract][Full Text] [Related]
23. Raised serum 25-hydroxyvitamin D levels in patients with active diabetic foot ulcers.
Afarideh M; Ghanbari P; Noshad S; Ghajar A; Nakhjavani M; Esteghamati A
Br J Nutr; 2016 Jun; 115(11):1938-46. PubMed ID: 27153203
[TBL] [Abstract][Full Text] [Related]
24. [Revascularization of the lower limbs for ischemic diabetic foot with pyonecrotic tissue lesions].
Shor NA; Chumak IuF; Reuka VP; Zhukov OA
Angiol Sosud Khir; 2004; 10(4):85-9. PubMed ID: 15627142
[TBL] [Abstract][Full Text] [Related]
25. Biomarkers for early diagnosis of type 2 diabetic nephropathy: a study based on an integrated biomarker system.
Huang M; Liang Q; Li P; Xia J; Wang Y; Hu P; Jiang Z; He Y; Pang L; Han L; Wang Y; Luo G
Mol Biosyst; 2013 Aug; 9(8):2134-41. PubMed ID: 23719966
[TBL] [Abstract][Full Text] [Related]
26. Severe Vitamin D3 Deficiency in the Majority of Patients with Diabetic Foot Ulcers.
Feldkamp J; Jungheim K; Schott M; Jacobs B; Roden M
Horm Metab Res; 2018 Aug; 50(8):615-619. PubMed ID: 29975973
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and Tissue Penetration of Ceftolozane-Tazobactam in Diabetic Patients with Lower Limb Infections and Healthy Adult Volunteers.
Monogue ML; Stainton SM; Baummer-Carr A; Shepard AK; Nugent JF; Kuti JL; Nicolau DP
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893779
[TBL] [Abstract][Full Text] [Related]
28. Osteoprotegerin and 25-hydroxy vitamin D levels in patients with diabetic foot.
Çağlar S; Çağlar A; Pilten S; Albay C; Beytemur O; Sarı H
Eklem Hastalik Cerrahisi; 2018 Dec; 29(3):170-5. PubMed ID: 30376802
[TBL] [Abstract][Full Text] [Related]
29. [Pathogenesis and combined surgical treatment of the pyonecrotic diabetic foot].
Svetukhin AM; Zemlianoĭ AB; Istratov VG; Korotkina RN; Terekhova RP; Puchkova LS; Makhmudova LS
Khirurgiia (Mosk); 2003; (3):85-8. PubMed ID: 12698661
[TBL] [Abstract][Full Text] [Related]
30. Acral Melanoma Mimicking Toe Gangrene in Diabetic Foot.
Han Y; Jia Z
Eur J Vasc Endovasc Surg; 2018 Jul; 56(1):118. PubMed ID: 29773286
[No Abstract] [Full Text] [Related]
31. [The coagulogram characteristics of patients with non-insulin-dependent diabetes mellitus].
Harbarchuk OI
Lik Sprava; 1999; (1):62-4. PubMed ID: 10424001
[TBL] [Abstract][Full Text] [Related]
32. Metabolic endotoxemia and diabetes mellitus: A systematic review.
Gomes JMG; Costa JA; Alfenas RCG
Metabolism; 2017 Mar; 68():133-144. PubMed ID: 28183445
[TBL] [Abstract][Full Text] [Related]
33. VEGF-A and PDGF-BB--angiogenic factors and the stage of diabetic foot syndrome advancement.
Drela E; Kulwas A; Jundziłł W; Góralczyk B; Boinska J; Drewniak W; Gadomska G; Rość D
Endokrynol Pol; 2014; 65(4):306-12. PubMed ID: 25185854
[TBL] [Abstract][Full Text] [Related]
34. [Charcot foot: A historical complication of diabetes?].
Reinhart F; Jochum G; Cordeanu M; Gaertner S; Miréa C; Stephan D
Presse Med; 2015 Oct; 44(10):1089-91. PubMed ID: 26337360
[No Abstract] [Full Text] [Related]
35. [Immune status in diabetic patients with pyo-necrotic lesions of lower extremities].
Zemlianoĭ AB; Pal'tsyn AA; Svetukhin AM; Kolokol'chikova EG; Chervonskaia NV; Badikova AK; Bobrovnikov AE; Puchkova LS; Grishina IA
Khirurgiia (Mosk); 2002; (1):34-5. PubMed ID: 11875946
[TBL] [Abstract][Full Text] [Related]
36. [Predictive value of test with procalcitonin in diagnostics of endogenous intoxication severity in extended purulent peritonitis].
Pavliak AIa
Klin Khir; 2011 Apr; (4):31-4. PubMed ID: 21698931
[TBL] [Abstract][Full Text] [Related]
37. Proinsulin-expressing dendritic cells in type 2 neuropathic diabetic patients with and without foot lesions.
Sambataro M; Sambado L; Trevisiol E; Cacciatore M; Furlan A; Stefani PM; Seganfreddo E; Durante E; Conte S; Della Bella S; Paccagnella A; Dei Tos AP
FASEB J; 2018 Jul; 32(7):3742-3751. PubMed ID: 29436863
[TBL] [Abstract][Full Text] [Related]
38. [The structure of microflora in ulcerative-necrotic lesions in patients with diabetic foot syndrome].
Beliaeva OA; Kryzhevskiĭ VV; Rybianets IuV; Korzhik NP; Ulanovich LI; Shevchenko AV; Bezuglaia EV
Klin Khir; 2010 Oct; (10):20-3. PubMed ID: 21290878
[TBL] [Abstract][Full Text] [Related]
39. [АRTERIAL PRESSURE ON THE FIRST TOE AS A PROGNOSIS CRITERION OF THE COMPLICATION OCCURRENCE IN THE DIABETIC FOOT SYNDROME ON BACKGROUND OF MENKEBERG’S SCLEROSIS].
Shapoval SD; Savon IL; Belinskaya VO; Maxymova OO; Yakunich AM
Klin Khir; 2017; (2):68-70. PubMed ID: 30273459
[TBL] [Abstract][Full Text] [Related]
40. A false diabetic foot ulcer.
Guarneri C; Cannavò SP; Bevelacqua V; Urso C
J Am Geriatr Soc; 2011 Oct; 59(10):1964-6. PubMed ID: 22091511
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
